Alyeska Investment Group’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4M Buy
+275,000
New +$8.98M 0.03% 396
2025
Q4
Sell
-207,393
Closed -$5.44M 760
2025
Q3
$5.44M Sell
207,393
-571,177
-73% -$13.6M 0.02% 448
2025
Q2
$16.6M Buy
778,570
+350,000
+82% +$7.9M 0.06% 300
2025
Q1
$9.11M Hold
428,570
0.04% 318
2024
Q4
$8.68M Hold
428,570
0.03% 351
2024
Q3
$7.2M Buy
+428,570
New +$7.22M 0.04% 319

Other funds holding GRDN

Alyeska Investment Group's GRDN Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 275,000 shares worth $10.4M. The stake represents 0.03% of the portfolio and ranks #396 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in GRDN as recently as Q3 2025.

Alyeska Investment Group first reported a position in GRDN in Q3 2024 and has held it in 6 quarters since. The position peaked at $16.6M in Q2 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Alyeska Investment Group held 275,000 shares of Guardian Pharmacy Services worth $10.4M as of Q1 2026.
  • Guardian Pharmacy Services was a new Alyeska Investment Group position in Q1 2026.
  • Guardian Pharmacy Services made up 0.03% of Alyeska Investment Group's portfolio in Q1 2026, its #396 holding.
  • Alyeska Investment Group first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 6 quarters since.
  • Alyeska Investment Group's Guardian Pharmacy Services position peaked at $16.6M in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.